Comments
Bharat Biotech has sought permission from Drug Controller General of India (DCGI) to extend the shelf-life of it's Covid-19 vaccine, Covaxin, from six to 24 months. The Hyderabad-based company submitted necessary real-time stability data of Covaxin to the drug regulator to substantiate its application, according to sources.
As of now, Covaxin has an approved shelf-life of six months subjec to its storage at two to eight degrees celsius. The shelf-life, however, can be extended to 24 months at the same temperature levels, the company has contended. As of now, Covishield of Serum Institute, the only other Covid vaccine being distributed in the country along with Covaxin, has an approved shelf-life of nine months.
A longer shelf-life, if approved, will allow the vaccine maker to ramp up production without any concern over possible stock pile-ups.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.